Validity of the ESSENCE‐Q neurodevelopmental screening tool in Japan
Developmental Medicine & Child Neurology · 2024
DOI: 10.1111/dmcn.15956 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, 2024. Verfasst von Kahoko Yasumitsu-Lovell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of the Environment of Japan, Ministry of the Environment, Government of Japan.
Abstract (Originalsprache)
Aim
To assess the validity of the Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations–Questionnaire (ESSENCE‐Q), a simple screening tool for neurodevelopmental problems, in Japan.
Method
Parents/caregivers completed the 11‐item ESSENCE‐Q for 77 612 children aged 2 years 6 months included in a national birth cohort study. Information about neurodevelopmental disorders (NDDs: autism spectrum disorder; intellectual disability and/or developmental language disorder; motor delay/motor disorder) was collected at age 3 years. Each ESSENCE‐Q item was scored on a binary (0,1) scale, with a total score range of 0 to 11. Total scores and individual items were compared across children with and without NDDs.
Results
NDDs were recorded in 854 children (1.1%). With a total ESSENCE‐Q score cut‐off of ≥3, receiver operating characteristic curve analysis showed an area under the curve of 0.91, with sensitivity 84.9%, specificity 84.8%, positive predictive value 5.9%, and negative predictive value 99.8%. The proportion of parental concerns at 2 years 6 months differed significantly by NDD status for communication (89.5% vs 14.2%) and general development (80.2% vs 7.4%). ESSENCE‐Q total scores were moderately negatively correlated (−0.36, p < 0.001) with Japanese Ages and Stages Questionnaire scores.
Interpretation
The parent/caregiver‐completed ESSENCE‐Q is useful as a tool for screening out children with neurotypical development at this early age. Further research into longer‐term predictive validity will be possible as more NDD diagnoses are given as the children grow up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Kochi Gillberg Neuropsychiatry Centre, Kochi, Japan.
- Department of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
- Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
- School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
ORCID-Profile: Kahoko Yasumitsu-Lovell, Lucy Thompson, Elisabeth Fernell, Masamitsu Eitoku, Narufumi Suganuma, Christopher Gillberg
Förderung
- Ministry of the Environment of Japan
- Ministry of the Environment, Government of Japan
Zitieren
APA
Yasumitsu-Lovell, K., Thompson, L., Fernell, E., Eitoku, M., Suganuma, N., Gillberg, C., & Japan Environment and Children's Study Group (2024). Validity of the ESSENCE‐Q neurodevelopmental screening tool in Japan. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15956
Vancouver
Yasumitsu-Lovell K, Thompson L, Fernell E, Eitoku M, Suganuma N, Gillberg C, et al. Validity of the ESSENCE‐Q neurodevelopmental screening tool in Japan. Developmental Medicine & Child Neurology. 2024. doi:10.1111/dmcn.15956
BibTeX
@article{YasumitsuLovell2024,
author = {Yasumitsu-Lovell, Kahoko and Thompson, Lucy and Fernell, Elisabeth and Eitoku, Masamitsu and Suganuma, Narufumi and Gillberg, Christopher and Japan Environment and Children's Study Group, Japan Environment and Children's Study Group},
title = {Validity of the ESSENCE‐Q neurodevelopmental screening tool in Japan},
journal = {Developmental Medicine & Child Neurology},
year = {2024},
doi = {10.1111/dmcn.15956}
}
EUVIMED